About 8,970,000 results
Open links in new tab
  1. Feedback
  2. Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior …

  3. Arcturus’ COVID-19 Vaccine Triggers Enhanced …

    WEB2 days ago · A trial comparing the self-replicating mRNA-based COVID-19 vaccine, developed by U.S. biotech Arcturus Therapeutics in collaboration with CSL, with BioNTech/Pfizer’s Comirnaty vaccine shows it is able to …

  4. Arcturus Therapeutics Presents New Clinical Data at 47th Annual ...

  5. What to Know About the New COVID-19 Strain 'Arcturus'

  6. New COVID Variant Arcturus XBB.1.16, Explained

    WEBApr 26, 2023 · What exactly is the XBB.1.16 Arcturus subvariant, which symptoms should people look out for, and is it more transmissible compared to other omicron subvariants? We spoke to experts to find out ...

  7. What to know about XBB.1.16, the 'Arcturus' variant - NBC News

  8. "Arcturus" COVID variant: Does it cause pink eye, and what

  9. New Symptom and More: What to Know About New …

    WEBApr 17, 2023 · The "Arcturus" variant, also known as XBB.1.16, is a highly transmissible omicron subvariant that causes conjunctivitis, or pink eye, in some cases. Learn about its spread, severity and how to prevent it in …

  10. New COVID-19 Variants Giving ‘Arcturus’ a Run for its …

    WEBJul 7, 2023 · XBB.1.16, or arcturus, was responsible for more than 17% of new COVID-19 infections over the past two weeks, according to estimates from the Centers for Disease Control and Prevention.

  11. Some results have been removed
We've updated our Terms of Use. Learn more